Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$441,636
+$86,897 QoQ
Shares Held
2,818
+9.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#946
of 1,603 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026StoneX Group Inc. holds $35,939,835 across 13 Drug Manufacturers - General names. NVS ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,707 | $8,230,389 | |
| 2 | LLY |
ELI LILLY & Co
|
6,635 | $7,958,218 | |
| 3 | JNJ |
Johnson & Johnson
|
27,201 | $6,908,237 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,565 | $5,469,602 | |
| 5 | AMGN |
Amgen Inc
|
12,416 | $4,496,081 | |
| 6 | PFE |
Pfizer Inc
|
33,470 | $805,957 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,503 | $547,562 | |
| 8 | NVS |
Novartis AG
This page
|
2,818 | $441,636 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $441,636 | 2,818 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | $354,739 | 2,573 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $286,103 | 2,231 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $269,126 | 2,224 | Shares | Defined | 2025-08-13 | |
| 2021-09-30 | $8,600,720 | 105,169 | Shares | Defined | 2021-10-20 | |
| No filing history on record for this holder in this stock. | ||||||